Am. J. Respir. Cell Mol. Biol., Vol 12, No. 6, 06 1995, 589-596.
CYP2E1 is preferentially expressed in Clara cells of murine lung: localization by in situ hybridization and immunohistochemical methods
PG Forkert
Department of Anatomy and Cell Biology, Queens University, Kingston, Ontario, Canada.
The purpose of this study was to investigate the expression and
distribution of pulmonary CYP2E1 in mice. The CYP2E1 protein and mRNA were
identified by immunoblotting and northern blotting, respectively, while the
distribution of the CYP2E1 protein and mRNA was examined by
immunohistochemistry and in situ hybridization, respectively. Protein
immunoblotting revealed a single band of approximately M(r) 51,000 in lung
microsomes of CD-1 male mice. Northern blotting with a 32P-labeled RNA
probe for CYP2E1 detected a single species of approximately 2 kb that was
similar in size to that of liver CYP2E1. Immunohistochemical studies with
the avidin-biotin complex procedure showed that CYP2E1 was localized
prominently in the nonciliated Clara cells but was not detected in the
ciliated cells of the bronchiolar epithelium. In the lung parenchyma,
immunoreactivity for CYP2E1 was evident at minimal levels in alveolar type
II cells. In situ hybridization experiments with a 33P-labeled RNA probe
showed that the CYP2E1 mRNA was also predominantly localized in the
bronchiolar epithelium and was most prominent in the Clara cells. As was
found for the CYP2E1 protein, the CYP2E1 mRNA was minimal in cells of the
lung parenchyma. These results demonstrated that the CYP2E1 enzyme is
preferentially expressed in Clara cells of murine lung. The concentration
of CYP2E1 mainly in this cell population may be an important determinant
underlying its susceptibility to cytotoxicities induced by xenobiotics
bioactivated by this P450 isozyme.
This article has been cited by other articles:

|
 |

|
 |
 
K. J. Ritchie, C. J. Henderson, X. J. Wang, O. Vassieva, D. Carrie, P. B. Farmer, M. Gaskell, K. Park, and C. R. Wolf
Glutathione Transferase {pi} Plays a Critical Role in the Development of Lung Carcinogenesis following Exposure to Tobacco-Related Carcinogens and Urethane
Cancer Res.,
October 1, 2007;
67(19):
9248 - 9257.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. G. Hernandez and P.-G. Forkert
Inhibition of vinyl carbamate-induced mutagenicity and clastogenicity by the garlic constituent diallyl sulfone in F1 (Big Blue(R) x A/J) transgenic mice
Carcinogenesis,
August 1, 2007;
28(8):
1824 - 1830.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. P. Black, K. S. Collins, D. P. Blacquiere, and P.-G. Forkert
FORMATION OF N-ALKYLPROTOPORPHYRIN IX FROM METABOLISM OF DIALLYL SULFONE IN LUNG AND LIVER
Drug Metab. Dispos.,
June 1, 2006;
34(6):
895 - 900.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-G. Forkert, B. Millen, L. H. Lash, D. A. Putt, and B. I. Ghanayem
Pulmonary Bronchiolar Cytotoxicity and Formation of Dichloroacetyl Lysine Protein Adducts in Mice Treated with Trichloroethylene
J. Pharmacol. Exp. Ther.,
February 1, 2006;
316(2):
520 - 529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-G. Forkert, R. M. Baldwin, B. Millen, L. H. Lash, D. A. Putt, M. A. Shultz, and K. S. Collins
PULMONARY BIOACTIVATION OF TRICHLOROETHYLENE TO CHLORAL HYDRATE: RELATIVE CONTRIBUTIONS OF CYP2E1, CYP2F, AND CYP2B1
Drug Metab. Dispos.,
October 1, 2005;
33(10):
1429 - 1437.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Simmonds, C. A. Reilly, R. M. Baldwin, B. I. Ghanayem, D. L. Lanza, G. S. Yost, K. S. Collins, and P.-G. Forkert
BIOACTIVATION OF 1,1-DICHLOROETHYLENE TO ITS EPOXIDE BY CYP2E1 AND CYP2F ENZYMES
Drug Metab. Dispos.,
September 1, 2004;
32(9):
1032 - 1039.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Simmonds, B. I. Ghanayem, A. Sharma, C. A. Reilly, B. Millen, G. S. Yost, and P.-G. Forkert
Bioactivation of 1,1-Dichloroethylene by CYP2E1 and CYP2F2 in Murine Lung
J. Pharmacol. Exp. Ther.,
September 1, 2004;
310(3):
855 - 864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-G. Forkert, L. Lash, R. Tardif, N. Tanphaichitr, C. Vandevoort, and M. Moussa
Identification of Trichloroethylene and Its Metabolites in Human Seminal Fluid of Workers Exposed to Trichloroethylene
Drug Metab. Dispos.,
March 1, 2003;
31(3):
306 - 311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-G. Forkert and S. M. Boyd
Differential Metabolism of 1,1-Dichloroethylene in Livers of A/J, CD-1, and C57BL/6 Mice
Drug Metab. Dispos.,
November 1, 2001;
29(11):
1396 - 1402.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-G. Forkert, S. M. Boyd, and J. B. Ulreich
Pulmonary Bioactivation of 1,1-Dichloroethylene Is Associated with CYP2E1 Levels in A/J, CD-1, and C57BL/6 Mice
J. Pharmacol. Exp. Ther.,
June 1, 2001;
297(3):
1193 - 1200.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. P. Titis and P.-G. Forkert
Strain-Related Differences in Bioactivation of Vinyl Carbamate and Formation of DNA Adducts in Lungs of A/J, CD-1, and C57BL/6 Mice
Toxicol. Sci.,
January 1, 2001;
59(1):
82 - 91.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-G. Forkert, P. D. Premdas, and R. J. Bowers
Epoxide Formation from Diallyl Sulfone Is Associated with CYP2E1 Inactivation in Murine and Human Lungs
Am. J. Respir. Cell Mol. Biol.,
November 1, 2000;
23(5):
687 - 695.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. D. Premdas, R. J. Bowers, and P.-G. Forkert
Inactivation of Hepatic CYP2E1 by an Epoxide of Diallyl Sulfone
J. Pharmacol. Exp. Ther.,
June 1, 2000;
293(3):
1112 - 1120.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P.-G. Forkert
In Vivo Formation and Localization of 1,1-Dichloroethylene Epoxide in Murine Liver: Identification of Its Glutathione Conjugate 2-S-Glutathionyl Acetate
J. Pharmacol. Exp. Ther.,
September 1, 1999;
290(3):
1299 - 1306.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P.-G. Forkert
1,1-Dichloroethylene-Induced Clara Cell Damage Is Associated with In Situ Formation of the Reactive Epoxide . Immunohistochemical Detection of Its Glutathione Conjugate
Am. J. Respir. Cell Mol. Biol.,
June 1, 1999;
20(6):
1310 - 1318.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Lam, J. C. leRiche, Y. Zheng, A. Coldman, C. MacAulay, E. Hawk, G. Kelloff, and A. F. Gazdar
Sex-Related Differences in Bronchial Epithelial Changes Associated With Tobacco Smoking
J Natl Cancer Inst,
April 21, 1999;
91(8):
691 - 696.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-G. Forkert, A. M. Malkinson, P. Rice, and M. Moussa
Diminished CYP2E1 Expression and Formation of 2-S-Glutathionyl Acetate, a Glutathione Conjugate Derived from 1,1-Dichloroethylene Epoxide, in Murine Lung Tumors
Drug Metab. Dispos.,
January 1, 1999;
27(1):
68 - 73.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P.-G. Forkert, D. D'Costa, and M. El-Mestrah
Expression and Inducibility of Alpha, Pi, and Mu Glutathione S-Transferase Protein and mRNA in Murine Lung
Am. J. Respir. Cell Mol. Biol.,
January 1, 1999;
20(1):
143 - 152.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Lee, K. C. Watt, A.-M. Chang, C. G. Plopper, A. R. Buckpitt, and K. E. Pinkerton
Site-Selective Differences in Cytochrome P450 Isoform Activities. Comparison of Expression in Rat and Rhesus Monkey Lung and Induction in Rats
Drug Metab. Dispos.,
May 1, 1998;
26(5):
396 - 400.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. P. Lee, A. Parkinson, and P.-G. Forkert
Isozyme-Selective Metabolism of Ethyl Carbamate by Cytochrome P450 (CYP2E1) and Carboxylesterase (Hydrolase A) Enzymes in Murine Liver Microsomes
Drug Metab. Dispos.,
January 1, 1998;
26(1):
60 - 65.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. E. Gram
Chemically Reactive Intermediates and Pulmonary Xenobiotic Toxicity
Pharmacol. Rev.,
December 1, 1997;
49(4):
297 - 342.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 American Thoracic Society.
|
|
|